The risk of developing cardiotoxicity due to 5-FU and capecitabine treatment is quite significant, the incidence ranging between 0.55 and 19% [ 63 ].
← all excerpts
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms.
1
—
—